Report of a child with vitiligo and Evans syndrome.
Muwakkit
Samar
S
Locatelli
Franco
F
Abboud
Miguel
M
Razzouk
Bassem
B
Wilimas
Judith
J
D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000150:complications* / Q000628:therapy; D017153:Antibodies, Anticardiolipin / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001327:Autoimmune Diseases / Q000097:blood / Q000150:complications* / Q000628:therapy; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004485:Eczema / Q000150:complications; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007239:Infections / Q000209:etiology; D008297:Male; D016269:Milk Hypersensitivity / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D012480:Salmonella Infections / Q000150:complications; D013577:Syndrome; D013921:Thrombocytopenia / Q000097:blood / Q000150:complications* / Q000628:therapy; D014820:Vitiligo / Q000097:blood / Q000150:complications*; D015215:Zidovudine / Q000627:therapeutic use
D017153:Antibodies, Anticardiolipin; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D015215:Zidovudine; D000069283:Rituximab; D016572:Cyclosporine; D011241:Prednisone